Ranibizumab ophthalmic and Zoladex (Goserelin Implant 10.8 mg)
Determining the interaction of Ranibizumab ophthalmic and Zoladex (Goserelin Implant 10.8 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Zoladex (Goserelin Implant 3.6 mg)
- Ranibizumab ophthalmic-Zoladex 3-Month
- Ranibizumab ophthalmic-Zoladex Implant
- Ranibizumab ophthalmic-Zolate
- Ranibizumab ophthalmic-Zoledronic acid
- Ranibizumab ophthalmic-Zoledronic Acid (Bone Health)
- Zoladex (Goserelin Implant 10.8 mg)-Ranitidine
- Zoladex (Goserelin Implant 10.8 mg)-Ranitidine Capsule
- Zoladex (Goserelin Implant 10.8 mg)-Ranitidine Hydrochloride
- Zoladex (Goserelin Implant 10.8 mg)-Ranitidine Injection
- Zoladex (Goserelin Implant 10.8 mg)-Ranitidine Suspension
- Zoladex (Goserelin Implant 10.8 mg)-Ranitidine Syrup